| Net Cash Provided by (Used in) Operating Activities |
$1,999,680 |
USD |
62% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,870,254 |
USD |
-45% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$4,578 |
USD |
87% |
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
1,560,820 |
shares |
-81% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$930,693 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$836,556 |
USD |
145% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$20,441,833 |
USD |
30% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$20,466,947 |
USD |
20% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$4,578 |
USD |
152% |
Q1 2024 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$50,700,026 |
USD |
-0.22% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$6,155 |
USD |
-95% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$121,567 |
USD |
|
Q1 2024 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$13,309,416 |
USD |
30% |
Q4 2024 |
FY 2024 |
| Current Income Tax Expense (Benefit) |
$56,000 |
USD |
|
Q3 2024 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
|
Q2 2025 |
Q2 2025 |
| Unrecognized Tax Benefits |
$26,462 |
USD |
56% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$141,431,240 |
USD |
18% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2024 |
Q1 2024 |
| Amortization of Intangible Assets |
$198,000 |
USD |
|
Q3 2024 |
Q3 2024 |
| Depreciation, Depletion and Amortization |
$206,700 |
USD |
12073% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$25,114 |
USD |
-98% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$411,177 |
USD |
-79% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |